Prognostic nutritional index, a novel biomarker which predicts worse prognosis in diffuse large B cell lymphoma
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 110, 106664
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysisCancer Cell International, 2020
- Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal TypeFrontiers in Oncology, 2020
- Systemic Immune-Inflammation Index Predicting Survival Outcome in Patients with Classical Hodgkin LymphomaBiomarkers in Medicine, 2019
- The Value of Prognostic Nutritional Index in Follicular LymphomaAmerican Journal of Clinical Oncology, 2019
- The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal typeAnnals of Hematology, 2015
- The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysisJournal of Cancer Research and Clinical Oncology, 2014
- Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)The Lancet Oncology, 2008
- CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) GroupThe Lancet Oncology, 2006
- Factors influencing serum albumin in dialysis patientsAmerican Journal of Kidney Diseases, 1998
- Prognostic nutritional index in gastrointestinal surgeryThe American Journal of Surgery, 1980